Ultrasound echocardiogram of a patient taking a test for heart diseases. Echocardiogram monitor with an image of patient's heart. Medical ultrasound scan. Blumberg is a contributor for TIME Your heart ...
Interim Analysis of Data from Cohort 1 Demonstrate Substantial Effects of CK-274 to Reduce LVOT Gradient in Patients with Obstructive Hypertrophic Cardiomyopathy with No Dose Interruptions Due to Left ...
Beta-blockers have been the initial treatment for symptomatic obstructive hypertrophic cardiomyopathy (HCM) despite limited evidence of their efficacy. Aficamten is a cardiac myosin inhibitor that ...
The investigational, next-generation cardiac myosin inhibitor aficamten (previously CK-274, Cytokinetics) continues to show promise as a potential treatment for hypertrophic cardiomyopathy (HCM).
A 42-year-old woman with obstructive hypertrophic cardiomyopathy (HCM) was referred for alcohol septal ablation (ASA). She had been diagnosed with HCM 20 years earlier following presentation with ...
But if you have HCM, you can make a number of lifestyle choices to protect your heart health and enjoy a high quality of life. Heavy lifting is potentially risky when you’re living with HCM, because ...
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced that the first patient has been dosed in Cohort 2 of REDWOOD-HCM (Randomized Evaluation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results